Literature DB >> 23123447

Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma.

Vishnudutt Purohit1, Rao Rapaka, Oh Sang Kwon, B J Song.   

Abstract

The purpose of this report is to summarize the roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma (HCC). Chronic heavy alcohol exposure is a major risk factor for HCC, which is the most frequent type of liver cancer. Alcohol ingestion may initiate and or promote the development of HCC by: 1) acetaldehyde-DNA adduct formation; 2) cytochrome P4502E1-associated reactive oxygen species (ROS) generation , lipid peroxidation, p53 mutation, and conversion of pro-carcinogens to carcinogens; 3) iron accumulation that leads to ROS generation, lipid peroxidation, p53 mutation, and initiation of inflammatory cascade via nuclear factor-KappaB (NF-kB) activation; 4) glutathione depletion leading to oxidative stress; 5) s-adenosylmethionine (SAM) depletion and associated DNA hypomethylation of oncogenes ; 6) retinoic acid depletion and resultant hepatocyte proliferation via up-regulation of activator protein-1 (AP-1); 7) initiating an inflammatory cascade through increased transfer of endotoxin from intestine to liver, Kupffer cell activation via CD14/toll-like receptor-4 (TLR-4), oxidative stress, NF-kB or early growth response-1(Egr-1) activation, and generation of inflammatory cytokines and chemokines; 8) induction of liver fibrosis; and 9) decreasing the number and/or function of natural killer cells. Tobacco exposure is also a risk factor for HCC. It may contribute to the initiation and promotion of HCC due the presence of mutagenic and carcinogenic compounds as well as by causing oxidative stress due to generation of ROS and depletion of endogenous antioxidants. Simultaneous exposure to alcohol and tobacco is expected to promote the development of HCC in an additive and/or synergistic manner. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123447      PMCID: PMC3822918          DOI: 10.1016/j.lfs.2012.10.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  131 in total

1.  Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese.

Authors:  Megumi Hara; Keitaro Tanaka; Tatsuhiko Sakamoto; Yasuki Higaki; Toshihiko Mizuta; Yuichiro Eguchi; Tsutomu Yasutake; Iwata Ozaki; Kyosuke Yamamoto; Shingo Onohara; Seiji Kawazoe; Hirohisa Shigematsu; Shunzo Koizumi
Journal:  Cancer Sci       Date:  2007-10-22       Impact factor: 6.716

2.  Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis.

Authors:  Hong-na Pan; Rui Sun; Barbara Jaruga; Feng Hong; Won-Ho Kim; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2006-09       Impact factor: 3.455

Review 3.  The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology.

Authors:  G Lenaz
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

4.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Methyl groups in carcinogenesis: effects on DNA methylation and gene expression.

Authors:  E Wainfan; L A Poirier
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

6.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

7.  Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.

Authors:  L Shen; J Fang; D Qiu; T Zhang; J Yang; S Chen; S Xiao
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

8.  Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism.

Authors:  Alina L Micu; Sharon Miksys; Edward M Sellers; Dennis R Koop; Rachel F Tyndale
Journal:  J Pharmacol Exp Ther       Date:  2003-05-15       Impact factor: 4.030

9.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

Review 10.  Iron and liver cancer.

Authors:  Yves Deugnier
Journal:  Alcohol       Date:  2003-06       Impact factor: 2.405

View more
  30 in total

Review 1.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.

Authors:  Bruna Paola Murino Rafacho; Camilla Peach Stice; Chun Liu; Andrew S Greenberg; Lynne M Ausman; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

3.  Mediation by peer violence victimization of sexual orientation disparities in cancer-related tobacco, alcohol, and sexual risk behaviors: pooled youth risk behavior surveys.

Authors:  Margaret Rosario; Heather L Corliss; Bethany G Everett; Stephen T Russell; Francisco O Buchting; Michelle A Birkett
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

Review 4.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

Review 5.  Friend or foe, the role of EGR-1 in cancer.

Authors:  Tong-Tong Li; Man-Ru Liu; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2019-11-20       Impact factor: 3.064

Review 6.  Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Authors:  Masayoshi Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

7.  Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Authors:  Keisuke Amano; Takumi Kawaguchi; Ryoko Kuromatsu; Atsushi Kawaguchi; Ichiro Miyajima; Tatsuya Ide; Tatsuyuki Kakuma; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-08-21

8.  Differential effects of alcohol and its metabolite acetaldehyde on vascular smooth muscle cell Notch signaling and growth.

Authors:  Ekaterina Hatch; David Morrow; Weimin Liu; Paul A Cahill; Eileen M Redmond
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-08       Impact factor: 4.733

Review 9.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

10.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.